Fight Continues Against Trump Administration Changes to 340B Drug Discount Program

(MedPage Today) -- The federal government's 340B program, which provides deeply discounted drugs to hospitals that serve low-income patients, continues to be a source of controversy for hospitals and drug companies. Earlier this month, the American...

Read it at MedPage Today ↗

← Front page